The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $83.76

Today's change+0.82 +0.99%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $83.76

Today's change+0.82 +0.99%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.

Endo International PLC up (U.S.)$0.82

Endo International PLC closed up Friday by (U.S.)$0.82 or 0.99% to (U.S.)$83.76. Shares have lost 1.37% over the last five days, but have gained 16.14% over the last year to date. This security has outperformed the S&P 500 by 8.90% during the last year.

Key company metrics

  • Open(U.S.) $84.45
  • Previous close(U.S.) $82.94
  • High(U.S.) $85.28
  • Low(U.S.) $83.68
  • Bid / Ask-- / --
  • YTD % change+16.14%
  • Volume3,565,027
  • Average volume (10-day)3,620,993
  • Average volume (1-month)2,420,360
  • Average volume (3-month)2,486,177
  • 52-week range(U.S.) $57.14 to (U.S.) $96.58
  • Beta1.18
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward18.33×
  • Forward PEG1.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.98
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.62%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue714800764719
Total other revenue--------
Total revenue714800764719
Gross profit330376385373
Total cost of revenue384424379346
Total operating expense6698721,098634
Selling / general / administrative212192205172
Research & development18403141
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)5621548276
Other operating expenses, total--------
Operating income45-72-33485
Interest income (expense), net non-operating-74-61-62-53
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-120-39139
Income after tax150-57-25224
Income tax, total-167-63-13916
Net income-76-53-25221
Total adjustments to net income--------
Net income before extra. items150-57-25224
Minority interest0001
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items150-57-25224
Inc. avail. to common incl. extra. items-76-53-25221
Diluted net income-76-53-25221
Dilution adjustment--000
Diluted weighted average shares170154153163
Diluted EPS excluding extraordinary itemsvalue per share0.89-0.37-1.640.15
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.100.580.430.47